Rapid Dose Therapeutics Corp. (CSE:DOSE)
0.0950
+0.0050 (5.56%)
Nov 20, 2026, 3:12 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 13.09 million as of November 20, 2026. It is the 41,567th most valuable company in the world and the 1,372nd biggest in Canada. Its market cap has decreased by 45.51% in one year.
Market Cap
13.09M
Enterprise Value
18.96M
Revenue
2.12M
Global Rank
Country Rank
#1,372 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 13.09M, a decrease of -79.47%. That is a compound annual growth rate of -18.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 13.09M | -25.85% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 20.21M |
| Defence Therapeutics | 19.41M |
| Devonian Health Group | 17.52M |
| Alzai Health | 17.17M |
| Medicenna Therapeutics | 17.08M |
| Lobe Sciences | 16.98M |
| Pharmala Biotech Holdings | 16.45M |
| PreveCeutical Medical | 12.76M |